Clinical trials
Recruiting Phase 3 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
477 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 8 |
| 2020 | 1 |
| 2021 | 15 |
| 2022 | 24 |
| 2023 | 35 |
| 2024 | 69 |
| 2025 | 162 |
| 2026 | 157 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 477 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 53 |
| Pfizer | 34 |
| Eli Lilly and Company | 31 |
| Merck Sharp & Dohme LLC | 30 |
| Janssen Research & Development, LLC | 21 |
| GlaxoSmithKline | 19 |
| Novartis Pharmaceuticals | 19 |
| Bristol-Myers Squibb | 16 |
| Takeda | 16 |
| Boehringer Ingelheim | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 37 |
| Obesity | 21 |
| Overweight | 20 |
| Breast Neoplasms | 15 |
| Multiple Myeloma | 14 |
| Crohn Disease | 13 |
| Diabetes Mellitus, Type 2 | 12 |
| Lung Neoplasms | 12 |
| Neoplasms | 12 |
| Ovarian Neoplasms | 12 |
Trials
Showing 1 to 25 of 477. Each trial links to its page on Pharma Observatory.
377 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.